Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-605 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-605 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
filingDate |
1997-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eda4b4a61df66a1e10de587c08148d75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5aa5b25bb30d1c5df319c979411aebc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea1188d5ee42f8044b941fb9b1fd85e7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f723aa0ccf82be22daa60d893791cbf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f8bfe7c8cf79bfa8136ea8fba911c6e |
publicationDate |
1997-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2243718-A1 |
titleOfInvention |
Diabetes therapy |
abstract |
The invention provides a gene therapy method for delivering safe and effective, long-term amounts of GLP-1(7-37)-based proteins useful for treating Type I and Type II diabetes. The invention eliminates the need for subcutaneous injections and is able to provide tight glucose control. |
priorityDate |
1996-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |